These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 35411503)
1. Construction and Functional Evaluation of a Three-Dimensional Blood-Brain Barrier Model Equipped With Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells. Kurosawa T; Sako D; Tega Y; Debori Y; Tomihara Y; Aoyama K; Kubo Y; Amano N; Deguchi Y Pharm Res; 2022 Jul; 39(7):1535-1547. PubMed ID: 35411503 [TBL] [Abstract][Full Text] [Related]
2. Expression and Functional Characterization of Drug Transporters in Brain Microvascular Endothelial Cells Derived from Human Induced Pluripotent Stem Cells. Kurosawa T; Tega Y; Higuchi K; Yamaguchi T; Nakakura T; Mochizuki T; Kusuhara H; Kawabata K; Deguchi Y Mol Pharm; 2018 Dec; 15(12):5546-5555. PubMed ID: 30376629 [TBL] [Abstract][Full Text] [Related]
3. Functional Investigation of Solute Carrier Family 35, Member F2, in Three Cellular Models of the Primate Blood-Brain Barrier. Mochizuki T; Mizuno T; Kurosawa T; Yamaguchi T; Higuchi K; Tega Y; Nozaki Y; Kawabata K; Deguchi Y; Kusuhara H Drug Metab Dispos; 2021 Jan; 49(1):3-11. PubMed ID: 33144341 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Glycogen Synthase Kinase 3ß Enhances Functions of Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells in the Blood-Brain Barrier. Yamaguchi T; Nishijima M; Kawabata K Biol Pharm Bull; 2022; 45(10):1525-1530. PubMed ID: 36184511 [TBL] [Abstract][Full Text] [Related]
5. Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells. Pong S; Lizano P; Karmacharya R J Vis Exp; 2020 Nov; (165):. PubMed ID: 33283783 [TBL] [Abstract][Full Text] [Related]
6. Matrix stiffness regulates the tight junction phenotypes and local barrier properties in tricellular regions in an iPSC-derived BBB model. Yan L; Dwiggins CW; Moriarty RA; Jung JW; Gupta U; Brandon KD; Stroka KM Acta Biomater; 2023 Sep; 167():109-120. PubMed ID: 37302732 [TBL] [Abstract][Full Text] [Related]
7. Development and Functional Evaluation of MDR1-expressing Microvascular Endothelial-like Cells Derived from Human iPS Cells as an In vitro Blood-brain Barrier Model. Yamaguchi T; Sako D; Kurosawa T; Nishijima M; Miyano A; Kubo Y; Ohtsuki S; Kawabata K; Deguchi Y J Pharm Sci; 2023 Dec; 112(12):3216-3223. PubMed ID: 37690777 [TBL] [Abstract][Full Text] [Related]
8. A human pluripotent stem cell-derived in vitro model of the blood-brain barrier in cerebral malaria. Gopinadhan A; Hughes JM; Conroy AL; John CC; Canfield SG; Datta D Fluids Barriers CNS; 2024 May; 21(1):38. PubMed ID: 38693577 [TBL] [Abstract][Full Text] [Related]
9. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs. Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318 [TBL] [Abstract][Full Text] [Related]
10. Functional brain-specific microvessels from iPSC-derived human brain microvascular endothelial cells: the role of matrix composition on monolayer formation. Katt ME; Linville RM; Mayo LN; Xu ZS; Searson PC Fluids Barriers CNS; 2018 Feb; 15(1):7. PubMed ID: 29463314 [TBL] [Abstract][Full Text] [Related]
11. Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line. Ozgür B; Puris E; Brachner A; Appelt-Menzel A; Oerter S; Balzer V; Holst MR; Christiansen RF; Hyldig K; Buckley ST; Kristensen M; Auriola S; Jensen A; Fricker G; Nielsen MS; Neuhaus W; Brodin B Fluids Barriers CNS; 2023 Dec; 20(1):96. PubMed ID: 38115090 [TBL] [Abstract][Full Text] [Related]
12. Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells. Hollmann EK; Bailey AK; Potharazu AV; Neely MD; Bowman AB; Lippmann ES Fluids Barriers CNS; 2017 Apr; 14(1):9. PubMed ID: 28407791 [TBL] [Abstract][Full Text] [Related]
13. The maturation of iPS cell-derived brain microvascular endothelial cells by inducible-SOX18 expression. Zhang H; Yamaguchi T; Kawabata K Fluids Barriers CNS; 2023 Feb; 20(1):10. PubMed ID: 36732767 [TBL] [Abstract][Full Text] [Related]
14. Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D. Jamieson JJ; Linville RM; Ding YY; Gerecht S; Searson PC Fluids Barriers CNS; 2019 Jun; 16(1):15. PubMed ID: 31167667 [TBL] [Abstract][Full Text] [Related]
16. A Perfused In Vitro Human iPSC-Derived Blood-Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies. Burgio F; Gaiser C; Brady K; Gatta V; Class R; Schrage R; Suter-Dick L Cell Mol Neurobiol; 2023 Nov; 43(8):4173-4187. PubMed ID: 37698826 [TBL] [Abstract][Full Text] [Related]
17. Comparison of organ-specific endothelial cells in terms of microvascular formation and endothelial barrier functions. Uwamori H; Ono Y; Yamashita T; Arai K; Sudo R Microvasc Res; 2019 Mar; 122():60-70. PubMed ID: 30472038 [TBL] [Abstract][Full Text] [Related]
18. RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability. Feng S; Zou L; Wang H; He R; Liu K; Zhu H Molecules; 2018 Sep; 23(9):. PubMed ID: 30227623 [TBL] [Abstract][Full Text] [Related]
19. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening. Wang YI; Abaci HE; Shuler ML Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645 [TBL] [Abstract][Full Text] [Related]
20. Large-Scale Quantitative Comparison of Plasma Transmembrane Proteins between Two Human Blood-Brain Barrier Model Cell Lines, hCMEC/D3 and HBMEC/ciβ. Masuda T; Hoshiyama T; Uemura T; Hirayama-Kurogi M; Ogata S; Furukawa A; Couraud PO; Furihata T; Ito S; Ohtsuki S Mol Pharm; 2019 May; 16(5):2162-2171. PubMed ID: 30983357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]